Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production - PubMed (original) (raw)

. 2007 Jul 6;317(5834):121-4.

doi: 10.1126/science.1140485.

Affiliations

Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production

Willscott E Naugler et al. Science. 2007.

Erratum in

Abstract

Hepatocellular carcinoma (HCC), the most common liver cancer, occurs mainly in men. Similar gender disparity is seen in mice given a chemical carcinogen, diethylnitrosamine (DEN). DEN administration caused greater increases in serum interleukin-6 (IL-6) concentration in males than it did in females. Furthermore, ablation of IL-6 abolished the gender differences in hepatocarcinogenesis in mice. DEN exposure promoted production of IL-6 in Kupffer cells (KCs) in a manner dependent on the Toll-like receptor adaptor protein MyD88, ablation of which also protected male mice from DEN-induced hepatocarcinogenesis. Estrogen inhibited secretion of IL-6 from KCs exposed to necrotic hepatocytes and reduced circulating concentrations of IL-6 in DEN-treated male mice. We propose that estrogen-mediated inhibition of IL-6 production by KCs reduces liver cancer risk in females, and these findings may be used to prevent HCC in males.

PubMed Disclaimer

Comment in

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources